Damon Reed, MD

Memorial Sloan Kettering
New York, New York, United States

Presentation(s):

• Paper 04 - SECOND MALIGNANT NEOPLASM IN NON-METASTATIC EWING SARCOMA PATIENTS ENROLLED ON PHASE 3 CLINICAL TRIALS: A FOLLOW-UP REPORT FROM CHILDRENS ONCOLOGY GROUP (COG)

  Thursday, November 13, 2025
  10:30 AM - 11:30 AM EST

  Disclosure information not submitted.

• Paper 11 - TGFβ IMPRINTED NK CELLS WITH CHEMOTHERAPY FOR RELAPSED SARCOMA: PART 1 RESULTS, A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION

  Thursday, November 13, 2025
  1:30 PM - 3:00 PM EST

  Disclosure information not submitted.

• Paper 22 - DISSECTING TUMOR HETEROGENEITY AND CELL STATE-SPECIFIC THERAPEUTIC TARGETS FROM SINGLE-NUCLEI RNA-SEQ OF CIC::DUX4 ROUND CELL SARCOMA

  Thursday, November 13, 2025
  4:15 PM - 5:30 PM EST

  Disclosure information not submitted.

• Paper 65 - ASSOCIATION OF CLINICO-PATHOLOGIC FEATURES AND MOLECULAR GENOTYPES WITH OUTCOMES OF SYSTEMIC THERAPY IN METASTATIC SOFT TISSUE LEIOMYOSARCOMA (LMS) PATIENTS

  Saturday, November 15, 2025
  9:00 AM - 10:30 AM EST

  Disclosure information not submitted.